Fifty-eight HIV-positive drug abusers and 22 HIV-positive nondrug abus
ers at stages II-III and IV of the Centers for Disease Control classif
ication were evaluated neuropsychologically. The study confirmed previ
ous findings that drug abuse has a negative influence on cognitive fun
ction. It also emerges that serepositivity affects cognitive function,
although the poor performance of group II-III patients compared to gr
oup IV may be explained by factors related to seropositivity (anxiety
and panic) rather than the disease itself. It is concluded that diseas
e-related factors probably determine cognitive performance in the earl
ier stages of HIV infection.